436 related articles for article (PubMed ID: 10097121)
1. Pathogenetic sequence for aneurysm revealed in mice underexpressing fibrillin-1.
Pereira L; Lee SY; Gayraud B; Andrikopoulos K; Shapiro SD; Bunton T; Biery NJ; Dietz HC; Sakai LY; Ramirez F
Proc Natl Acad Sci U S A; 1999 Mar; 96(7):3819-23. PubMed ID: 10097121
[TBL] [Abstract][Full Text] [Related]
2. Targetting of the gene encoding fibrillin-1 recapitulates the vascular aspect of Marfan syndrome.
Pereira L; Andrikopoulos K; Tian J; Lee SY; Keene DR; Ono R; Reinhardt DP; Sakai LY; Biery NJ; Bunton T; Dietz HC; Ramirez F
Nat Genet; 1997 Oct; 17(2):218-22. PubMed ID: 9326947
[TBL] [Abstract][Full Text] [Related]
3. Marfan syndrome: new clues to genotype-phenotype correlations.
Ramirez F; Gayraud B; Pereira L
Ann Med; 1999 Jun; 31(3):202-7. PubMed ID: 10442675
[TBL] [Abstract][Full Text] [Related]
4. Phenotypic alteration of vascular smooth muscle cells precedes elastolysis in a mouse model of Marfan syndrome.
Bunton TE; Biery NJ; Myers L; Gayraud B; Ramirez F; Dietz HC
Circ Res; 2001 Jan; 88(1):37-43. PubMed ID: 11139471
[TBL] [Abstract][Full Text] [Related]
5. Induction of macrophage chemotaxis by aortic extracts of the mgR Marfan mouse model and a GxxPG-containing fibrillin-1 fragment.
Guo G; Booms P; Halushka M; Dietz HC; Ney A; Stricker S; Hecht J; Mundlos S; Robinson PN
Circulation; 2006 Oct; 114(17):1855-62. PubMed ID: 17030689
[TBL] [Abstract][Full Text] [Related]
6. IL-6 regulates extracellular matrix remodeling associated with aortic dilation in a fibrillin-1 hypomorphic mgR/mgR mouse model of severe Marfan syndrome.
Ju X; Ijaz T; Sun H; Lejeune W; Vargas G; Shilagard T; Recinos A; Milewicz DM; Brasier AR; Tilton RG
J Am Heart Assoc; 2014 Jan; 3(1):e000476. PubMed ID: 24449804
[TBL] [Abstract][Full Text] [Related]
7. Fibrillin-1 genetic deficiency leads to pathological ageing of arteries in mice.
Mariko B; Pezet M; Escoubet B; Bouillot S; Andrieu JP; Starcher B; Quaglino D; Jacob MP; Huber P; Ramirez F; Faury G
J Pathol; 2011 May; 224(1):33-44. PubMed ID: 21432852
[TBL] [Abstract][Full Text] [Related]
8. Therapy insight: aortic aneurysm and dissection in Marfan's syndrome.
Ramirez F; Dietz HC
Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):31-6. PubMed ID: 16265257
[TBL] [Abstract][Full Text] [Related]
9. Ascending aortic aneurysm with or without features of Marfan syndrome and other fibrillinopathies: new insights.
Furthmayr H; Francke U
Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):191-205. PubMed ID: 9263339
[TBL] [Abstract][Full Text] [Related]
10. miR-29b participates in early aneurysm development in Marfan syndrome.
Merk DR; Chin JT; Dake BA; Maegdefessel L; Miller MO; Kimura N; Tsao PS; Iosef C; Berry GJ; Mohr FW; Spin JM; Alvira CM; Robbins RC; Fischbein MP
Circ Res; 2012 Jan; 110(2):312-24. PubMed ID: 22116819
[TBL] [Abstract][Full Text] [Related]
11. Doxycycline delays aneurysm rupture in a mouse model of Marfan syndrome.
Xiong W; Knispel RA; Dietz HC; Ramirez F; Baxter BT
J Vasc Surg; 2008 Jan; 47(1):166-72; discussion 172. PubMed ID: 18178469
[TBL] [Abstract][Full Text] [Related]
12. Mutations of extracellular matrix components in vascular disease.
Ramirez F; Pereira L
Ann Thorac Surg; 1999 Jun; 67(6):1857-8; discussion 1868-70. PubMed ID: 10391325
[TBL] [Abstract][Full Text] [Related]
13. The fibrillins.
Ramirez F; Pereira L
Int J Biochem Cell Biol; 1999 Feb; 31(2):255-9. PubMed ID: 10216958
[TBL] [Abstract][Full Text] [Related]
14. A Gly1127Ser mutation in an EGF-like domain of the fibrillin-1 gene is a risk factor for ascending aortic aneurysm and dissection.
Francke U; Berg MA; Tynan K; Brenn T; Liu W; Aoyama T; Gasner C; Miller DC; Furthmayr H
Am J Hum Genet; 1995 Jun; 56(6):1287-96. PubMed ID: 7762551
[TBL] [Abstract][Full Text] [Related]
15. Identification of fibrillin 1 gene mutations in patients with bicuspid aortic valve (BAV) without Marfan syndrome.
Pepe G; Nistri S; Giusti B; Sticchi E; Attanasio M; Porciani C; Abbate R; Bonow RO; Yacoub M; Gensini GF
BMC Med Genet; 2014 Feb; 15():23. PubMed ID: 24564502
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of GxxPG fragments ameliorates manifestations of aortic disease in Marfan syndrome mice.
Guo G; Muñoz-García B; Ott CE; Grünhagen J; Mousa SA; Pletschacher A; von Kodolitsch Y; Knaus P; Robinson PN
Hum Mol Genet; 2013 Feb; 22(3):433-43. PubMed ID: 23100322
[TBL] [Abstract][Full Text] [Related]
17. Mechanical assessment of elastin integrity in fibrillin-1-deficient carotid arteries: implications for Marfan syndrome.
Ferruzzi J; Collins MJ; Yeh AT; Humphrey JD
Cardiovasc Res; 2011 Nov; 92(2):287-95. PubMed ID: 21730037
[TBL] [Abstract][Full Text] [Related]
18. Nanoscale Structural Comparison of Fibrillin-1 Microfibrils Isolated from Marfan and Non-Marfan Syndrome Human Aorta.
Șulea CM; Mártonfalvi Z; Csányi C; Haluszka D; Pólos M; Ágg B; Stengl R; Benke K; Szabolcs Z; Kellermayer MSZ
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108724
[TBL] [Abstract][Full Text] [Related]
19. Fibrillins 1 and 2 perform partially overlapping functions during aortic development.
Carta L; Pereira L; Arteaga-Solis E; Lee-Arteaga SY; Lenart B; Starcher B; Merkel CA; Sukoyan M; Kerkis A; Hazeki N; Keene DR; Sakai LY; Ramirez F
J Biol Chem; 2006 Mar; 281(12):8016-23. PubMed ID: 16407178
[TBL] [Abstract][Full Text] [Related]
20. Fibrillin-rich microfibrils: Structural determinants of morphogenetic and homeostatic events.
Ramirez F; Dietz HC
J Cell Physiol; 2007 Nov; 213(2):326-30. PubMed ID: 17708531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
